Home › NDC Lookup › RxCUI directory › RxCUI 835572

Imipramine pamoate 75 MG Oral Capsule — RxCUI 835572

RxNorm drug concept · Semantic clinical drug
RxCUI 835572 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI835572
Official nameImipramine pamoate 75 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)1,865 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Imipramine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's common to not notice a change right away — imipramine typically takes one to three weeks before you feel a meaningful difference in your mood. Some people take even longer. Tr...
  • How long does it take for imipramine to start working for depression?
  • It's best to avoid alcohol entirely while on imipramine. This medication intensifies the sedating effects of alcohol, so even a small amount can make you feel much more drowsy or i...
  • Is it safe to drink alcohol while taking imipramine?
📖 Read our full Imipramine guide →

🕸️ Concept Web — How Imipramine pamoate 75 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Imipramine pamoate 75 MG Oral Capsule RxCUI 835572

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Imipramine 5691
    • Imipramine pamoate 91118
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Imipramine Oral Capsule 370680
    • Imipramine pamoate Oral Capsule 2647271
    • Imipramine Oral Product 1156294
    • Imipramine Pill 1156295
    • Imipramine pamoate Oral Product 2662673
    • Imipramine pamoate Pill 2662639
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Imipramine pamoate 75 MG 835571

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Imipramine pamoate 75 MG SCDC · 835571
  • Imipramine Oral Capsule SCDF · 370680
  • Imipramine pamoate Oral Capsule SCDFP · 2647271
  • Imipramine Oral Product SCDG · 1156294
  • Imipramine Pill SCDG · 1156295
  • Imipramine pamoate Oral Product SCDGP · 2662673
  • Imipramine pamoate Pill SCDGP · 2662639

📦 FDA Products & Package NDCs

8 products · 8 package NDCs
8 package NDCs map to RxCUI 835572 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0273-13 30 CAPSULE in 1 BOTTLE (0054-0273-13) Imipramine Pamoate Hikma Pharmaceuticals USA Inc 2010-04-19
00054-0274-13 30 CAPSULE in 1 BOTTLE (0054-0274-13) Imipramine Pamoate Hikma Pharmaceuticals USA Inc 2010-04-19
00054-0275-13 30 CAPSULE in 1 BOTTLE (0054-0275-13) Imipramine Pamoate Hikma Pharmaceuticals USA Inc 2010-04-19
00054-0276-13 30 CAPSULE in 1 BOTTLE (0054-0276-13) Imipramine Pamoate Hikma Pharmaceuticals USA Inc 2010-04-19
68180-0314-06 30 CAPSULE in 1 BOTTLE (68180-314-06) Imipramine Pamoate Lupin Pharmaceuticals, Inc. 2010-04-16
68180-0315-06 30 CAPSULE in 1 BOTTLE (68180-315-06) Imipramine Pamoate Lupin Pharmaceuticals, Inc. 2010-04-16
68180-0316-06 30 CAPSULE in 1 BOTTLE (68180-316-06) Imipramine Pamoate Lupin Pharmaceuticals, Inc. 2010-04-16
68180-0317-06 30 CAPSULE in 1 BOTTLE (68180-317-06) Imipramine Pamoate Lupin Pharmaceuticals, Inc. 2010-04-16
Observed labelers: Hikma Pharmaceuticals USA Inc (4) · Lupin Pharmaceuticals, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.